chr2-119245683-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_182915.3(STEAP3):c.217C>T(p.Arg73Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000682 in 1,613,760 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_182915.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STEAP3 | NM_182915.3 | c.217C>T | p.Arg73Cys | missense_variant | 3/6 | ENST00000393110.7 | NP_878919.2 | |
STEAP3-AS1 | NR_046721.1 | n.1957G>A | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STEAP3 | ENST00000393110.7 | c.217C>T | p.Arg73Cys | missense_variant | 3/6 | 1 | NM_182915.3 | ENSP00000376822 | ||
STEAP3-AS1 | ENST00000654197.1 | n.1359G>A | non_coding_transcript_exon_variant | 4/4 |
Frequencies
GnomAD3 genomes AF: 0.000434 AC: 66AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000390 AC: 98AN: 251170Hom.: 0 AF XY: 0.000435 AC XY: 59AN XY: 135762
GnomAD4 exome AF: 0.000708 AC: 1034AN: 1461412Hom.: 0 Cov.: 31 AF XY: 0.000702 AC XY: 510AN XY: 726926
GnomAD4 genome AF: 0.000433 AC: 66AN: 152348Hom.: 0 Cov.: 33 AF XY: 0.000349 AC XY: 26AN XY: 74504
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 11, 2022 | The c.217C>T (p.R73C) alteration is located in exon 3 (coding exon 2) of the STEAP3 gene. This alteration results from a C to T substitution at nucleotide position 217, causing the arginine (R) at amino acid position 73 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 27, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with STEAP3-related conditions. This variant is present in population databases (rs138657061, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 63 of the STEAP3 protein (p.Arg63Cys). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at